News Jawbone liquidates - but will return with clinical focus Jawbone Health Hub will focus on clinical health wearables.
Views & Analysis Digital Health Round-up – The Curious Case of Theranos, and ... A round-up of this week’s top digital healthcare news. Marco Ricci reports.
Views & Analysis Digital health round-up – Rio Olympics; AZ’s digital plans A round-up of this week’s top digital healthcare news.
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
